{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T14:43:57Z","timestamp":1720622637794},"reference-count":13,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1080\/0891693031000153803","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T18:41:11Z","timestamp":1068576071000},"page":"317-319","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: Induction of T-cell Tolerance in a Patient with Idiopathic Thrombocytopenic Purpura by Single Injection of Humanized Monoclonal Antibody to CD40 Ligand"],"prefix":"10.1080","volume":"36","author":[{"given":"Shosaku","family":"Nomura","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, Kansai Medical University, 10\u201315 Fumizono-cho, Moriguchi, 570-8507, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"The Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikeda","family":"Yasuo","sequence":"additional","affiliation":[{"name":"The Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12118-8"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.5.1284.1284"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2423059.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4238"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.14.6550"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401002"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/367425a0"},{"key":"e_1_2_1_10_1","first-page":"95","volume":"28","author":"Davis J.C.","year":"2001","unstructured":"Davis, J.C., Totoritis, MC., Rosenberg, J., Sklenar, TA. and Wofsy, D. (2001) \"Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus\", J. Rheumatol. 28, 95\u2013101.","journal-title":"J. Rheumatol"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2157"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.7.2309.2309"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.7.3675"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.130"}],"container-title":["Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/0891693031000153803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:46:55Z","timestamp":1720619215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/0891693031000153803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1080\/0891693031000153803"],"URL":"https:\/\/doi.org\/10.1080\/0891693031000153803","relation":{},"ISSN":["0891-6934","1607-842X"],"issn-type":[{"value":"0891-6934","type":"print"},{"value":"1607-842X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}